Dr. Thomas Acke
ActiveSummary
Dr. Thomas Acke has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €235,976 and a net result of €112,188. The computed 12-month bankruptcy probability is 0.2% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 26-10-2023 Normal situation
- Activity
- “De uitoefening van de geneeskunde en meer specifiek de specialisatie de geriatrie” (deed in Dutch)From the articles, 10 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.351.276.040 9000 Gent, since 26-10-2023
- Financial year end
- 31 December
- Peppol
- Reachable since 18-06-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.2%
- Gross margin
- €144,785
- ▼ 4.9%
- Turnover
- ≈ €360,000
- estimated
- Profit
- €112,188
- ▼ 5.2%
- Equity
- €235,976
- ▲ 90.6%
- Total assets
- €271,973
- ▲ 71.9%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSize: total assets €271,973Liquidity: current ratio 7.48, cash €258,208Figures for financial year 2025 (filed on 16-06-2026)Show the evidence
Checked score
About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 89% on liquidity, 90% on profitability and 92% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 2 accounts on average 33 days before the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
Annual accounts 2025 filed on 16-06-2026 at the NBB all 2 filings
Every figure per financial year
The operating result for 2025 is 5% lower than in 2024.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2024 | 2025 |
|---|---|---|
| Tangible fixed assets | - | €3,126 |
| Depreciation and write-downs of the year | - | €403 |
Source: notes to the 2024 to 2025 annual accounts (statement of fixed assets)
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | €403 | - |
| Other operating charges640/8 | €873 | €966 | ▲ 10.7% |
| Gross operating margin9900 | €152,314 | €144,785 | ▼ 4.9% |
| Operating profit (loss)9901 | €151,441 | €143,416 | ▼ 5.3% |
| Financial charges65/66B | €53 | €60 | ▲ 13.2% |
| Recurring financial charges65 | €53 | €60 | ▲ 13.2% |
| Profit (loss) for the period before taxes9903 | €151,388 | €143,356 | ▼ 5.3% |
| Income taxes67/77 | €33,000 | €31,167 | ▼ 5.6% |
| Profit (loss) for the period9904 | €118,388 | €112,188 | ▼ 5.2% |
| Profit (loss) for the period to be appropriated9905 | €118,388 | €112,188 | ▼ 5.2% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Assets | |||
| Total assets20/58 | €158,249 | €271,973 | ▲ 71.9% |
| Fixed assets21/28 | - | €2,723 | - |
| Tangible fixed assets22/27 | - | €2,723 | - |
| Plant, machinery and equipment23 | - | €1,073 | - |
| Furniture and vehicles24 | - | €1,650 | - |
| Current assets29/58 | €158,249 | €269,250 | ▲ 70.1% |
| Amounts receivable within one year40/41 | €2,000 | €250 | ▼ 87.5% |
| Other amounts receivable41 | €2,000 | €250 | ▼ 87.5% |
| Cash at bank and in hand54/58 | €139,497 | €258,208 | ▲ 85.1% |
| Deferred charges and accrued income490/1 | €16,753 | €10,792 | ▼ 35.6% |
| Equity and liabilities | |||
| Total equity and liabilities10/49 | €158,249 | €271,973 | ▲ 71.9% |
| Equity10/15 | €123,788 | €235,976 | ▲ 90.6% |
| Contributions10/11 | €5,400 | €5,400 | = |
| Reserves13 | €118,388 | €230,576 | ▲ 94.8% |
| Distributable reserves133 | €118,388 | €230,576 | ▲ 94.8% |
| Amounts payable17/49 | €34,462 | €35,997 | ▲ 4.5% |
| Amounts payable within one year42/48 | €34,302 | €35,997 | ▲ 4.9% |
| Trade debts44 | €1,302 | €4,731 | ▲ 264% |
| Suppliers440/4 | €1,302 | €4,731 | ▲ 264% |
| Taxes, remuneration and social security45 | €33,000 | €31,266 | ▼ 5.3% |
| Taxes450/3 | €33,000 | €31,167 | ▼ 5.6% |
| Remuneration and social security454/9 | - | €98 | - |
| Accrued charges and deferred income492/3 | €160 | €0 | ▼ 100% |
| Line | 2024 | 2025 | Change |
|---|---|---|---|
| Profit (loss) for the period9904 | €118,388 | €112,188 | ▼ 5.2% |
| + Depreciation and write-downs630 | - | €403 | - |
| Operating cash flow (approximation) | €118,388 | €112,591 | ▼ 4.9% |
| Change in cash | - | €118,711 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 39,278 companies had the same profile as Dr. Thomas Acke has now. Two years later, 95.9% were still going and 1.8% had gone bankrupt.
- Micro
- 2 to 5 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
The bankruptcy probability of Dr. Thomas Acke itself is lower: 0.2% within 12 months. It rests on far more data about Dr. Thomas Acke than the profile alone.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,278 companies, not a prediction for Dr. Thomas Acke. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Board & ownership
Directors
Owners and capital
Shareholders
- ACKE Thomas Albert Victor 120 shares (100%) · €5,400 in cash
Capital transactions
- 30-10-2023 Incorporation · 120 shares
Articles of association
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- “Éénparige goedkeuring door bestaande aandeelhouders, ontbinding-vereffening of systematische statutenwijziging inzonderheid artikel 1 en…”
- Statutory auditorA statutory auditor is a registered auditor who checks the annual accounts. Small companies need not have one. According to the deed, the legal criteria do not require one here.
- No statutory auditor
Articles of association, deed of 30-10-2023 (in Dutch)
Network & group
Dr. Thomas Acke shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of Dr. Thomas Acke. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
20-03
Gazette deed
Registered office moved within Gent2 points ▸
- Board meeting, 17-02-2025
- Registered-office move, Francisco Ferrerlaan 94-96,9000 Gent
30-10
Gazette deed
IncorporationAppointment: ACKE Thomas Albert Victor (director) · Founder · Founding capital9 points ▸
- Founder, ACKE Thomas Albert Victor
- Incorporation, 25-10-2023
- Founding capital
- ACKE Thomas Albert Victor holds 120 shares
- Other provision, “statutair (on)beschikbare eigen vermogensrekening, beschikbare eigen vermogensrekening” (deed in Dutch)
- Registered office clause, “9050 Gent,Gentbrugge,Jan Dhondtstraat 24” (deed in Dutch)
- Director appointment, ACKE Thomas Albert Victor (director (not named in the articles))
- Pre-incorporation commitments
- ACKE Thomas Albert Victor holds all the shares
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
1 former office
- Jan Dhondtstraat 24, 9050 Gent until 01-11-2024 · act of 20-03-2025
Activities
10 activities
- De uitoefening van de geneeskunde en meer specifiek de specialisatie de geriatrie
- Het uitbaten van een praktijk in de meest ruime zin (bv. op vlak van accommodatie,apparatuur,medewerkers en algemene diensten)
- Het optreden als stagebegeleider
- Het zetelen in organen die zich interesseren in de geneeskunde of het zetelen in organen waarvoor het diploma van arts of een bijzondere beroepstitel wordt vereist
- Het organiseren van,verstrekken/verrichten van en deelnemen aan onderwijs,wetenschappelijk onderzoek,lezingen,seminaries,colloquia,cursussen en studiereizen verband houdend met de geneeskunde
- Het vervaardigen en uitgeven van publicaties verband houdend met de geneeskunde en het zetelen in redactieraden die zich interesseren in de geneeskunde
- Het verstrekken van medische adviezen en raadgevingen,ook als bijvoorbeeld controlearts
- Het meewerken aan (preventie)campagnes verband houdend met de geneeskunde
- Het verwerven van,beheren van,beschikken over en valoriseren van onroerend patrimonium en roerend patrimonium,omvattende alle handelingen met betrekking tot onroerende en roerende goederen (bv. verwerving,renovatie en verhandeling van onroerende goederen,verwerving en verhandeling van participaties in andere vennootschappen)
- Het verlenen van bijstand,advies en leiding aan andere entiteiten,bijvoorbeeld onder een bestuurdersmandaat
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 44810K0309/00Y000 | Flanders | 100 m² | 1 · 68 m² | 14.3 m · 4 |